practices

Chemsex: "patients change their practices when we take care of them and provide them with appropriate care"

Chemsex: “patients change their practices when we take care of them and provide them with appropriate care”

France – Different international studies have convergent results on Chemsex: it is a practice that concerns 20% to 30% of men who have sex with men and especially that is developing. In the infectious diseases department of the Saint-Louis hospital (Paris), where the number of patients practicing Chemsex is estimated at 1,000, dedicated consultations were …

Chemsex: “patients change their practices when we take care of them and provide them with appropriate care” Read More »

Par rapport à la chimiothérapie, le risque de progression est réduit de 49 % sous trastuzumab deruxtecan

Breast cancer: conjugated antibodies are changing practices!

Conjugation of an anti-HER2 monoclonal antibody and a topoisomerase I inhibitor, trastuzumab deruxtecan (T-Dxd, Enhertu) currently benefits in metastasis only tumors strongly overexpressing HER2, i.e. only approximately 15 to 20% of breast cancers. These tumors have either a 3+ score in immunohistochemistry (IHC), or 2+ with an overexpression confirmed by in situ hybridization (HIS+). But …

Breast cancer: conjugated antibodies are changing practices! Read More »